Abstract:Following the publication of the above article, a concerned reader drew to the Editor's attention that the Transwell cell invasion assay data featured in Figs. 3 and 5, and the cell microscopic/morphological images shown in Fig. 4A and C, were strikingly similar to data appearing in different form in other articles written by different authors at different research institutes that had either already been published elsewhere prior to the submission of this paper to Oncology Reports , or which under consideration for publication at around the same time (several of which have now been retracted). In addition, overlapping sections of data were noted within Figs. 3 and 5, such that data which were intended to represent the results from differently performed experiments had apparently been derived from the same original source(s). In view of the fact that certain of these data had already apparently been published prior to the submission of this article for publication, the Editor of Oncology Reports has decided that this paper should be retracted from the Journal. After having been in contact with the authors, they agreed with the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused. [Oncology Reports 36: 3105‐3112, 2016; DOI: 10.3892/or.2016.5146]

[Retracted] Increased resistin suggests poor prognosis and promotes development of lung adenocarcinoma

[Retracted] MicroRNA‑874 Inhibits Growth, Induces Apoptosis and Reverses Chemoresistance in Colorectal Cancer by Targeting X‑linked Inhibitor of Apoptosis Protein

[Retracted] Effect of RhoC on the epithelial‐mesenchymal transition process induced by TGF‐β1 in lung adenocarcinoma cells

[Retracted] Inhibiting Proliferation and Migration of Lung Cancer Using Small Interfering RNA Targeting on Aldo‑keto Reductase Family 1 Member B10.

[Retracted] lncRNA‑u50535 promotes the progression of lung cancer by activating CCL20/ERK signaling

[Retracted] Tissue‐specific transplantation antigen P35B functions as an oncogene and is regulated by microRNA‐125a‐5p in lung cancer

[Retracted] Schisandrin B inhibits epithelial‐mesenchymal transition and stemness of large‐cell lung cancer cells and tumorigenesis in xenografts via inhibiting the NF‐κB and p38 MAPK signaling pathways

[Retracted] LOC102724163 promotes breast cancer cell proliferation and invasion by stimulating MUC19 expression

[Retracted] Long non‐coding RNA TMCC1‐AS1 predicts poor prognosis and accelerates epithelial‐mesenchymal transition in liver cancer

[Retracted] SRC‐like adaptor protein negatively regulates Wnt signaling in intrahepatic cholangiocarcinoma

[Retracted] 2,3,5,4‐tetrahydroxy diphenylethylene‐2‐O‐glucoside inhibits the adhesion and invasion of A549 human lung cancer cells

[Retracted] MicroRNA‐34a expression affects breast cancer invasion in vitro and patient survival via downregulation of E2F1 and E2F3 expression

[Retracted] Downregulated microRNA‐140‐5p expression regulates apoptosis, migration and invasion of lung cancer cells by targeting zinc finger protein 800

[Retracted] ANRIL is associated with the survival rate of patients with colorectal cancer, and affects cell migration and invasion in vitro

[Retracted] Circular RNA NOX4 promotes the development of colorectal cancer via the microRNA‑485‑5p/CKS1B axis

[Retracted] CXCL5 promotes the proliferation and migration of glioma cells in autocrine‑ and paracrine‑dependent manners

[Retracted] Chronic oxymatrine treatment induces resistance and epithelial‐mesenchymal transition through targeting the long non‐coding RNA MALAT1 in colorectal cancer cells

[Retracted] Glutathione peroxidase 2 overexpression promotes malignant progression and cisplatin resistance of KRAS‐mutated lung cancer cells

[Retracted] Molecular mechanism of atractylon in the invasion and migration of hepatic cancer cells based on high‐throughput sequencing

[Retracted] miR‐17‐5p promotes the growth of osteosarcoma in a BRCC2‐dependent mechanism

[Retracted] Tumor suppressor miR‐613 induces cisplatin sensitivity in non‐small cell lung cancer cells by targeting GJA1